Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany
Authors:
- 15 October 2009
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 16 (11) , 1230-1232
Abstract
Background and purpose: Mutations in the leucine‐rich repeat kinase gene (LRRK2) have been shown to be the most common genetic cause of both familial and sporadic Parkinson’s disease. Patients harboring LRRK2 mutations develop late onset PD that in most cases cannot be clinically distinguished from idiopathic PD. Furthermore, LRRK2 mutations have been reported to result in a broad spectrum of neuropathological alterations including progressive supranuclear palsy (PSP)‐like Tau pathology.Methods: We screened a cohort of 88 clinically confirmed PSP patients for mutations in exon 31.Results: We did not find any of the known mutations or any new variants.Conclusions: Thus, there is no evidence that mutations in exon 31 of LRRK2 are a major risk factor for PSP. Our study, however, cannot rule out that other genetic variations in LRRK2 may be associated with PSP.Keywords
This publication has 21 references indexed in Scilit:
- Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late‐onset Parkinson's diseaseMovement Disorders, 2006
- Lrrk2 R1441 substitution and progressive supranuclear palsyNeuropathology and Applied Neurobiology, 2006
- Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1Annals of Neurology, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau geneAnnals of Neurology, 2004
- SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disordersMovement Disorders, 2003
- An R5L τ mutation in a subject with a progressive supranuclear palsy phenotypeAnnals of Neurology, 2002
- Steele‐Richardson‐Olszewski syndrome in a patient with a single C212Y mutation in the parkin proteinMovement Disorders, 2002
- Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau geneBrain, 2000
- Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)Neurology, 1996